Cumulative experience with terazosin administered in combination with diuretics

Area of Science:

• Pharmacology
• Cardiovascular Medicine
• Clinical Trials

Background:

• Hypertension remains a significant global health concern requiring effective treatment strategies.
• Diuretic therapy is a cornerstone in hypertension management.
• The role of alpha-blockers, such as terazosin, in combination therapy needs further elucidation.

Purpose of the Study:

• To evaluate the short-term antihypertensive efficacy of terazosin when added to a diuretic regimen.
• To assess the safety profile of combination therapy with terazosin and a diuretic.
• To compare the effectiveness of terazosin plus diuretic versus placebo plus diuretic.

Main Methods:

• Three randomized, double-blind, placebo-controlled studies were conducted.
• Participants received either terazosin in combination with a diuretic or a placebo with a diuretic.
• Blood pressure, pulse rate, physical examinations, electrocardiographic tracings, and laboratory tests were monitored.

Main Results:

• Combination therapy with terazosin and a diuretic resulted in significant incremental decreases in blood pressure compared to placebo.
• Satisfactory response rates were 56% for the terazosin group versus 29% for the placebo group.
• No significant changes in pulse rate or other safety parameters were observed; however, a slight tendency for weight gain and common side effects like dizziness and headache were noted.

Conclusions:

• Combination therapy with terazosin and a diuretic is a safe and effective short-term treatment for hypertension.
• Terazosin offers an effective add-on therapy to diuretics for blood pressure control.
• The safety profile supports the use of this combination in hypertensive patients, with monitoring for mild adverse effects.